Wet age-related macular degeneration (wAMD) management – the role and impact of anti-VEGF therapy – Certificate of Completion

On completion of this program, participants will be better able to:

1. Recall the pathophysiology and epidemiology of wAMD
2. Review approved treatment options for wAMD and appreciate the impact anti-vascular endothelial growth factor (VEGF) therapy has had on incidence of AMD-related blindness
3. Compare pharmacokinetics, efficacy, safety and practical dosing and treatment-related issues for anti-VEGF therapy options for wAMD
4. Evaluate clinical trial and real-world evidence on wAMD treatment outcomes